Dr. Wang graduated from Temple University in 2001 with MD and PhD degrees in biochemistry and mechanistic enzymology. He completed Internal Medicine residency at Yale-New Haven Hospital, followed by an Infectious Diseases Fellowship at the University of Pennsylvania. Upon the completion of his clinical training, Dr. Wang pursued his postdoctoral research fellowship in Microbiology, Virology and Genomics with Dr. Rick Bushman at the University of Pennsylvania. He joined UF in 2009 as an Assistant Professor, became Section Chief of Infectious Diseases at NF/SG VA in 2014, and was promoted to Associate Professor with tenure in 2016.
Dr. Wang cares for a large number of Veterans with HIV and HCV co-infection, and has clinical expertise in the management of HIV and HCV antiviral drug resistance and recurrent Clostridium difficile infection. He is a fellow of the Infectious Diseases Society of America and a member of the VA National HIV Technical Advisory Group. Dr. Wang is a permanent member of the NIH NIDDK-C study section, and a member of the VA Infectious Disease Merit Review Board. His laboratory, funded by the NIH, VA Merit Review, DoD, and industry, focuses on HIV and HCV antiviral drug resistance, and microbiome studies in C. difficile infection, chronic periodontitis, mental health, and cystic fibrosis. In addition, he is the site PI for two multi-center VA Cooperative Studies Programs and several clinical trials in HIV and C. difficile infection, including fecal microbiota transplant.
The Division warmly welcomes and supports Dr. Wang as he takes on his new role as Interim Chief of the Division of Infectious Diseases and Global Medicine.